Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone

NCT04296578 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study did not start

Conditions

Prostate Cancer
Castrate Resistant Prostate Cancer

Interventions

DRUG: Abiraterone Acetate
DRUG: Sodium Selenite
DRUG: Prednisone

Sponsor

Stanford University